• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

29.2700 USD 0.5500 1.84%

As of 20:10:00 ET on 07/31/2014.

Snapshot for Acorda Therapeutics Inc (ACOR)

Open: 31.3800 Day's Range: 29.0500 - 31.3800 Volume: 590,121
Previous Close: 29.8200 52wk Range: 27.5100 - 39.9450 1-Yr Rtn: -21.44%

Stock Chart for ACOR

No chart data available.
  • ACOR:US 29.2700
  • 1D
  • 1M
  • 1Y
29.8200
Interactive ACOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACOR

Current P/E Ratio (ttm) 63.0087
Estimated P/E(12/2014) 29.8369
Relative P/E vs. SPX 3.5849
Earnings Per Share (USD) (ttm) 0.4645
Est. EPS (USD) (12/2014) 0.9810
Est. PEG Ratio 0.5281
Market Cap (M USD) 1,221.53
Shares Outstanding (M) 41.73
30 Day Average Volume 534,111
Price/Book (mrq) 2.4412
Price/Sale (ttm) 3.3586
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACOR

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
More Company Profile & Key Executives for ACOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil